Jasper Therapeutics, Inc. (JSPR)

NASDAQ: JSPR · IEX Real-Time Price · USD

23.21

-0.61 (-2.56%)

At close: Apr 18, 2024, 4:00 PM

23.11

-0.10 (-0.43%)

After-hours: Apr 18, 2024, 5:28 PM EDT

Jasper Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-64.47	-37.69	-30.64	-31.67	-4.99
Depreciation & Amortization	1.53	1.31	0.57	0.02	0
Share-Based Compensation	5.21	4.09	1.05	1.21	0.01
Other Operating Activities	5.66	-13.57	-4.66	12.17	3.01
Operating Cash Flow	-52.07	-45.86	-33.68	-18.27	-1.97
Capital Expenditures	-0.27	-0.58	-2.43	0	0
Investing Cash Flow	-0.27	-0.58	-2.43	0	0
Share Issuance / Repurchase	101.93	0.06	95.51	0.05	0
Debt Issued / Paid	0	0	0	0	1.5
Other Financing Activities	-0.96	-	5.46	11.23	27.63
Financing Cash Flow	100.97	0.06	100.97	11.29	29.13
Net Cash Flow	48.64	-46.38	64.86	-6.98	27.16
Free Cash Flow	-52.33	-46.43	-36.11	-18.27	-1.97
Free Cash Flow Per Share	-5.01	-12.73	-31.69	-29.82	-4.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).